None.
Eur Rev Med Pharmacol Sci. 2024 May;28(10):3473. doi: 10.26355/eurrev_202405_36273.
The Editor in Chief and the Publisher are issuing an expression of concern to alert readers to the fact that the following articles are under investigation due to concerns raised regarding non-verifiable nucleotide sequences and cell lines used in the following articles: - Shi YX, Ye BL, Hu BR, Ruan XJ. Expression of miR-1294 is downregulated and predicts a poor prognosis in gastric cancer. Eur Rev Med Pharmacol Sci 2018; 22 (17): 5525-5530-DOI: 10.26355/eurrev_201809_15813-PMID: 30229824. - Dong SR, Ju XL, Yang WZ. STAT5A reprograms fatty acid metabolism and promotes tumorigenesis of gastric cancer cells. Eur Rev Med Pharmacol Sci 2019; 23 (19): 8360-8370-DOI: 10.26355/eurrev_201910_19147-PMID: 31646566. - Chen J, Yuan ZH, Hou XH, Shi MH, Jiang R. LINC01116 promotes the proliferation and inhibits the apoptosis of gastric cancer cells. Eur Rev Med Pharmacol Sci 2020; 24 (4): 1807-1814-DOI: 10.26355/eurrev_202002_20358-PMID: 32141549. Further updates will be provided once the investigation is completed. The authors have been notified about this expression of concern.
主编和出版者发布关注声明，提醒读者注意以下文章因核苷酸序列不可验证和以下文章中使用的细胞系存在问题而正在接受调查：- 石 XX、叶 BL、胡 BR、阮 XJ。miR-1294 的表达下调并预测胃癌预后不良。Eur Rev Med Pharmacol Sci 2018; 22 (17): 5525-5530-DOI: 10.26355/eurrev_201809_15813-PMID: 30229824。- 董 SR、鞠 XL、杨 WZ。STAT5A 重新编程脂肪酸代谢并促进胃癌细胞的肿瘤发生。Eur Rev Med Pharmacol Sci 2019; 23 (19): 8360-8370-DOI: 10.26355/eurrev_201910_19147-PMID: 31646566。- 陈 J、袁 ZH、侯 XH、施 MH、蒋 R。LINC01116 促进胃癌细胞的增殖并抑制其凋亡。Eur Rev Med Pharmacol Sci 2020; 24 (4): 1807-1814-DOI: 10.26355/eurrev_202002_20358-PMID: 32141549。一旦调查完成，将提供进一步的更新。作者已被告知此关注声明。
